Wellcome looks for backers of an $8B-plus Covid-19 fund; ReNeuron signs on another pharma partner
→ The nonprofit Wellcome is looking to raise $8 billion to fund the development of new drugs and vaccines that can fight Covid-19. The UK organization says that represents just a fraction of the money that’s been set aside to safeguard economies and would go a long way to funding an effective R&D campaign while scaling up manufacturing alongside the effort. Dubbed Covid-Zero, they’re hoping to have at least $8 billion in the fund by the end of this month. “Businesses and governments are rightly concerned with tackling immediate concerns – how to support staff, keep trading and bolster economies. But we also need a way out of this pandemic as fast as possible,” noted Jeremy Farrar, who runs Wellcome.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.